Ignite Creation Date:
2025-12-25 @ 3:53 AM
Ignite Modification Date:
2026-02-25 @ 11:02 PM
Study NCT ID:
NCT01888302
Status:
COMPLETED
Last Update Posted:
2016-06-21
First Post:
2013-06-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery
Sponsor:
Mayo Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-09
Start Date Type:
None
Primary Completion Date:
2016-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-06
Completion Date Type:
ACTUAL
First Submit Date:
2013-06-25
First Submit QC Date:
None
Study First Post Date:
2013-06-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-06-20
Last Update Post Date:
2016-06-21
Last Update Post Date Type:
ESTIMATED